Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.22.1
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Product sales, net $ 4,447 $ 4,844
Cost of goods sold 3,291 2,486
Gross profit 1,156 2,358
Operating expenses:    
Research and development 121 186
Selling, general and administrative 2,550 5,285
Total operating expenses 2,671 5,471
Operating loss (1,515) (3,113)
Interest expense 702 14
Net loss $ (2,217) $ (3,127)
Weighted average common shares outstanding, basic (shares) 116,834 104,508
Weighted average common shares outstanding, diluted (shares) 116,834 104,508
Net loss per share basic (in USD per share) $ (0.02) $ (0.03)
Net loss per share diluted (in USD per share) $ (0.02) $ (0.03)
Revenue, product and service [Extensible List] Product [Member] Product [Member]